Other users also viewed these articles
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Alvar Agusti; José Luis Lopez-Campos; Marc Miravitlles; Juan Jose Soler-Cataluña; Jose Maria Marin; Borja G. Cosio; Bernardino Alcázar-Navarrete; Jose Maria Echave-Sustaeta; Ciro Casanova; German Peces-Barba; Juan Pablo de-Torres; Alberto Fernandez-Villar; Julio Ancochea; Felipe Villar-Alvarez; Miguel Roman-Rodriguez; Jesus Molina; Juan Luis Garcia-Rivero; Cruz Gonzalez; Patricia Sobradillo; Rosa Faner; Carolina Peña; Raj Sharma; José Luis Izquierdo; Bartolome R. Celli;
Arch Bronconeumol. 2024;60:417-22
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Alvar Agustí; Bartolome R. Celli; Gerard J. Criner; David Halpin; Antonio Anzueto; Peter Barnes; Jean Bourbeau; MeiLan K. Han; Fernando J. Martinez; Maria Montes de Oca; Kevin Mortimer; Alberto Papi; Ian Pavord; Nicolas Roche; Sundeep Salvi; Don D. Sin; Dave Singh; Robert Stockley; M. Victorina López Varela; Jadwiga A. Wedzicha; Claus F. Vogelmeier;
Arch Bronconeumol. 2023;59:232-48
Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD
Marc Miravitlles; Myriam Calle; Jesús Molina; Pere Almagro; José-Tomás Gómez; Juan Antonio Trigueros; Efraín Sánchez-Angarita; Borja G. Cosío; Ciro Casanova; José Luis López-Campos; Juan Antonio Riesco; Pere Simonet; David Rigau; Ainel Iskakova; Mariano Pastor Sanz; Patricia Sobradillo; Bernardino Alcázar-Navarrete; Noé Garin; Juan José Soler-Cataluña;
Arch Bronconeumol. 2025;61:766-82